Welcome to the first issue of our deeper series. Twice a week, in between our single-study posts, I sit down with the new menopause literature and do what I'd do for a colleague: read the papers, weigh the evidence, and tell you what's worth your attention - and what isn't. Everything is referenced, so you or your doctor can check my work. Here's what the past week brought.
1. Hormone therapy may lift mood - especially when symptoms are severe
What it studied: A real-world study of 260 women, published in Menopause (the journal of The Menopause Society), asked what happens to mood when women start hormone therapy for its approved indications - hot flashes and genitourinary symptoms. This matters because mood disturbances - low mood, irritability, anxiety, mental exhaustion - affect somewhere between 45% and 68% of women in the transition.
What it found: The proportion of women with severe mood symptoms fell from 62.3% to 24.6% after starting therapy. The improvement was greatest in women whose symptoms were most severe at the start, and it held regardless of prior psychiatric diagnosis, antidepressant use, age, or menopause stage.
My read: This matches what I see in clinic - "I don't feel like myself anymore" is one of the most common sentences in menopause medicine. But this is a retrospective observational study, not a randomized trial: women who feel better may simply be those whose hot flashes and sleep improved. Mood benefits may be real but partly downstream of symptom relief. It is not a reason to prescribe hormones for depression - it is a reason to take mood seriously in every menopause conversation.
Citation: "Impact of hormone therapy on mood in a real-world clinical setting: a retrospective observational study." Menopause. Published online September 9, 2026. https://menopause.org/press-releases/hormone-therapy-use-may-to-lead-to-fewer-mood-disturbances-during-the-menopause-transition
2. Your brain's gray matter "pauses" its decline during late perimenopause
What it studied: A Nature Communications study - the first longitudinal comparison of brain structure across all three major female hormonal transitions - followed 1,095 brains through puberty, pregnancy, and menopause, scanning each participant twice.
What it found: Puberty and pregnancy bring marked gray matter loss - which researchers interpret as healthy neural fine-tuning, not damage. The surprise was menopause: the gradual age-related decline in gray matter temporarily leveled off during late perimenopause, then resumed after the final period. Hormone therapy use and number of children made no measurable difference.
My read: Reassuring and genuinely new. Menopause does not appear to accelerate structural brain loss the way puberty and pregnancy remodel the brain. But structure is not symptoms: the authors are explicit that this says nothing about the brain fog many women report, which may have more to do with sleep disruption and hormone fluctuation than with gray matter volume. Don't read this as "menopause is easy on the brain" - read it as "your brain is more stable through this than we assumed."
Citation: van't Hof S, et al. Nature Communications. September 8, 2026. https://www.nature.com/articles/s41467-026-76755-2
3. Earlier menopause, faster memory decline - and a window to act
What it studied: A JAMA Network Open study led by UCSF followed 2,603 older women (average age 78 at enrollment) for up to 18 years, with annual cognitive testing, brain scans in a subgroup, and autopsies in 1,287.
What it found: Women who reached menopause earlier showed faster decline in memory and general cognition, and were diagnosed with Alzheimer's earlier - models estimated roughly two fewer Alzheimer's-free years for every ten years earlier menopause. The association was stronger after surgical menopause. On MRI, women with earlier natural menopause accumulated about 15% more white matter damage (small-vessel injury) per decade per five years of earlier transition.
My read: The strongest signal here is vascular - and that's the encouraging part. Small-vessel brain health is one of the most modifiable contributors to brain aging: blood pressure, sleep, exercise, blood sugar. The authors frame perimenopause as a window of opportunity, and I agree. Caveats: observational data, recall of menstrual history, and group averages that don't predict any individual. Most women go through menopause and keep their brain health. If your menopause came early - especially surgically - this is a reason to be proactive about vascular risk factors, not a reason to panic.
Citation: Campagna MP, Schneider JA, Barnes LL, Arfanakis K, Levi Dunietz G, Bennett DA, Bove RM. "Age at Menopause and Brain Atrophy Among Older Women." JAMA Network Open. 2026. Summary: https://www.psypost.org/earlier-menopause-is-linked-to-faster-memory-decline-and-earlier-alzheimers-onset/
4. Pilates beats lifestyle education for menopausal symptoms - and mat works too
What it studied: A three-arm randomized controlled trial of 45 postmenopausal women with obesity: supervised Reformer Pilates, home-based Mat Pilates (twice weekly, 8 weeks), or a structured lifestyle education program.
What it found: Both Pilates groups improved menopausal symptoms significantly more than education, with no meaningful difference between Reformer and Mat on the primary outcome. Reformer pulled ahead on quality of life and some body composition measures. Depressive symptoms and sleep improved in all three groups - including education.
My read: Small trial, short follow-up, but randomized - a higher evidence tier than most of what fills your feed. The practical message is genuinely useful: you don't need studio equipment; a mat at home, twice a week, moved the needle. And the improvement in mood and sleep across all groups, including the education group, is a quiet reminder that structured attention and routine themselves help.
Citation: Kocamer MY, Atilgan E. Scientific Reports. September 10, 2026. https://doi.org/10.1038/s41598-026-69442-1
Also this week, in our single-study posts: hormone therapy timing and cardiovascular risk (SWAN, JAMA Internal Medicine - https://www.drhweiss.com/p/hormone-therapy-and-your-heart-what), and the gut-barrier study showing "leaky gut" markers rising years before the final period (Journal of Clinical Investigation - https://www.jci.org/articles/view/205059).
What's trending - and where it meets the evidence
You asked me to keep an eye on what menopause content is actually circulating. This week, four things:
The supplement boom is colliding with the evidence. Menopause supplements are all over TikTok and Instagram, and this week brought a cluster of warnings: UCL researchers called for better research after finding popular products lacking key ingredients with widely varying vitamin doses, and UK reports flagged safety concerns including vomiting, confusion, and liver damage. My position is simple: if a supplement claims to treat menopause symptoms, ask for the trial data first. Most don't have it.
The "perimenopause industrial complex" went mainstream. Wired published a major investigation into the telehealth menopause boom - subscriptions up to $200 a month, unregulated add-ons, and marketing that outruns the science (The Menopause Society's medical director called popular estrogen face creams "garbage"). Real hormone therapy, properly prescribed, is effective and recently had its FDA black box warning removed. The hype machine wrapping itself around that real medicine is the problem - expensive tests, proprietary blends, and fear sold back to you as empowerment.
The estrogen patch shortage is real. Women on Reddit and in the press are describing pharmacy scrambles for estradiol patches, with the shortage expected to persist through year's end. If your pharmacy is out, don't ration silently - call your doctor. There are alternative formulations (gels, sprays, other brands) and substitutions are routine.
"Progesterone sensitivity" is going viral. It's a social-media phrase, not a recognized diagnosis - though the underlying experience (feeling worse on the progestogen part of hormone therapy) is real and has real solutions, from dose changes to different progestogen types. If that sounds like you, it's a legitimate thing to raise - just don't let a hashtag define your care.
The bottom line
This week's science says: mood belongs in the menopause conversation; your brain's structure is steadier through the transition than we thought; early menopause is a reason to invest in vascular brain health; and a mat on your living-room floor is legitimate medicine. And this week's internet says what it always says - buy things. Bring me the claims; I'll keep bringing you the evidence.
Dr. Herman Weiss
Medical Disclaimer
The information provided in this blog post and newsletter is for educational and informational purposes only. It does not constitute medical advice or professional services and should not be used to diagnose or treat any health problem or disease. Always seek the advice of your physician or other qualified health-care provider regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read here.
Use of this content does not create a doctor-patient relationship. Individual responses to treatments and lifestyle changes can vary, and only your healthcare provider can evaluate your specific circumstances. If you are experiencing a medical emergency, call your local emergency services immediately.